Prevalence of colorectal polyp and cancer from colonoscopy screening in adults aged 45 and above, 2022-2024.
Keywords:
screening colonoscopy, colon polyps, colorectoal cancer, incidence, clinical practice, public healthAbstract
Introduction
Colorectal cancer represents a significant public health concern in Thailand, ranking as the third most common cancer among Thai people. Colonoscopy screening primarily emphasizes on those aged 50 and above, which aligns with Thai clinical practice guidelines. Meanwhile data regarding the prevalence of potentially precancerous polyps requiring removal in this age group remains limited in Thailand.
Objective
The main objective of this research is to determine the prevalence of colon polyps and colorectal cancer in the population aged 45 and above who underwent colonoscopy at Thammasat University Hospital between 2653 and 2567 BE. The secondary objective is to compare the prevalence of these lesions between genders and across age groups 45-49 years, 50-75 years, and 76 years and above.
Methods
This retrospective study analyzed electronic medical records of patients aged 45 and above who underwent screening colonoscopy at Thammasat University Hospital from 2022 to 2024. The analysis included demographic data, colonoscopy findings, including polyps and colon cancer prevalence across genders and age groups.
Results
A total of 993 participants were includedd in this study. All participants underwent colorectal cancer screening between 2020 and 2024, with annual enrollment of 214, 129, 179, 243, and 228 participants, respectively. 46.3% were male and 53.07% were female, with an age range of 45 to 90 years (mean 64.20 years). Of these, 17.72% were aged 45 to 50 years and 82.28% were aged 50 to 75 year old. Of all participants screened, 11.18% had colon polyps, and 16.82% were diagnosed with colon cancer. In the 45-49 age group, the prevalence of colon polyps was 15.09% and the prevalence of colon cancer was 13.21%. The prevalence of colon polyps There was no statistically significant difference in the prevalence of polyps and colon cancer in men and women (10.94% in men and 11.39% in women), as was the case for colon cancer (17.17% in men and 16.51% in women). The prevalence of polyps and colon cancer was also not statistically significant.
Conclusion
The findings demonstrate that colonic abnormalities in the 45-49 age group occur at a clinically significant rate of approximately 15.09% and 13.21% for colon polyp and cancer, respectively. This suggests that patients seeking colorectal cancer screening consultation at tertiary care facilities may benefit from initiating screening at age 45.
Keywords: Screening colonoscopy, Colon polyps, Colorectal cancer, Colorectal cancer incidence, Clinical practice , Public health
References
Globocan 2020. International Agency for Research on Cancer. World Health Organization.
สถาบันมะเร็งแห่งชาติ. รายงานทะเบียนมะเร็งระดับโรงพยาบาล พ.ศ. 2565
American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025.
Zauber AG, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-696.
NCCN Guidelines Version ๒.๒๐๒๓. Colorectal Cancer Screening.
แนวทางเวชปฏิบัติการคัดกรองมะเร็งลำไส้ใหญ่และไส้ตรง ราชวิทยาลัยอายุรแพทย์แห่งประเทศไทย พ.ศ. 2565
Heisser T, Kretschmann J, Hagen B, Niedermaier T, Hoffmeister M, Brenner H. Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120,000 Repeated Screening Colonoscopies. JAMA Intern Med. 2023;183(3):183-190. doi:10.1001/jamainternmed.2022.6215.
Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-30.
National Cancer Institute. Colorectal cancer. NCI Dictionary of Cancer Terms. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colorectal-cancer.
American Cancer Society. Colorectal Cancer Guideline. Available from: https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html
National Comprehensive Cancer Network (NCCN). Colorectal Cancer Screening Guidelines. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1429
Levin TR, Corley DA, Jensen CD, et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155(5):1383-1391.
Zhang J, Chen G, Li Z, et al. Colonoscopic screening is associated with reduced colorectal cancer incidence and mortality: a systematic review and meta-analysis. J Cancer. 2020;11(20):5953-5970.
Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254.
Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977.
Mehta SJ, Morris AM, Kupfer SS. Colorectal Cancer Screening Starting at Age 45 Years—Ensuring Benefits Are Realized by All. JAMA Netw Open. 2021;4(5):e2112593.
Knudsen AB, Wanzhou J, Chan AT, et al. Modeling the impact of colorectal cancer screening on incidence and mortality: a microsimulation study. Cancer Prev Res (Phila). 2019;12(4):255-264.
Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624-33.
Juul FE, Cross AJ, Schoen RE, et al. Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer. JAMA Netw Open. 2024;7(2):e240007.
Meirson T, Markel G, Goldstein DA. Survival outcomes of population-wide colonoscopy screening: reanalysis of the NordICC data. BMC Gastroenterol. 2024;24(1):414.
